Gene Query: TIMP1

Dataset Description Geneva Score
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 138.17
Role of cervicovaginal microbiota in genital inflammation 125.26
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 112.59
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 107.76
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 100.43
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 93.36
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 88.3
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 88.3
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 73.76
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 70.46
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 70.15
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 70.15
Transcriptomic analysis of human tonsillar TFH subsets 69.22
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 65.82
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 62.28
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 57.31
Generation and functional characterization of MDSC-like cells 56.93
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 55.61
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 53.61
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 52.3
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 51.38
Controlling for gene expression changes in transcription factor protein networks. 49.33
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 47.7
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 47.62
Global analyses of the effect of different cellular contexts on microRNA targeting 47.62
TOP2B disturbed the quality of human oocytes with advanced maternal age 45.81
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 45.53
ZIKV infection of monocytes activates inflammasome pathways 45.4
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 44.78
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 44.63
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 44.24
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 44.12
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 43.86
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 43.5
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 43.43
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 43.43
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 43.29
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 42.78
TCF7L1 knockdown in pancreatic cancer 42.12
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 41.91
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 41.81
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 41.27
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 41.11
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 40.91
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 38.14
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 37.26
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 36.69
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 36.25
MYCi361 regulates MYC target genes 35.72
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 35.6
RNA expression following TMPRSS11B overexpression or depletion 35.24
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 34.97
RNA Sequencing of three pairs of gastric cancer 34.84
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 34.82
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 34.82
RNA m5C Methylation in breast cancer using MeRIP-Seq 34.26
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 33.84
hnRNP C is a key regulator of protein synthesis in mitosis 33.84
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 33.8
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 33.75
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 33.73
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 33.46
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 33.35
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 33.27
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 33.17
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 33.06
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 32.42
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 31.9
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 31.8
DJ-1 is dispensable for human stem cell homeostasis 31.41
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 31.32
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 31.15
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 31.06
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 30.95
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 30.94
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 30.78
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 30.78
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 30.69
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 30.61
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 30.36
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 30.33
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 30.14
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 29.92
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 29.92
MYCi975 regulates MYC target genes 29.92
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 29.64
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 29.5
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 29.46
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 29.41
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 29.4
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 29.34
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 29.34
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 29.1
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 28.39
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 28.26
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 28.2
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 28.19
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 28.19
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 28.16
ARID1A and ARID1B loss in HCT116 cells 27.85
Anti-inflammatory effect of indoleacrylic acid (IA) 27.85
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 27.67
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 27.58
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 27.47
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 27.44
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 27.37
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 27.15
Investigation about fibroblasts of different origins in culture 27.14
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 26.89
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 26.87
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 26.63
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 26.56
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 26.51
Hepatocyte maturation 26.36
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 26.33
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 26.01
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 26.0
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 25.97
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 25.87
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 25.87
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 25.71
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 25.71
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 25.66
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 25.34
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 25.14
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 25.14
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 25.0
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 25.0
Proliferation-correlated expression 24.93
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 24.71
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 24.47
Role of CD133 molecule in WNT response and renal repair 24.27
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 24.19
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 24.01
The role of FAM46C in myeloma cells 23.86
The role of FAM46C in myeloma cells [sequencing] 23.86
Accurate annotation of human protein-coding small open reading frames 23.65
Dynamic 3D chromosomal landscapes in acute leukemia 23.6
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 23.6
Ectoderm specification of H1 human embryonic stem cells 23.18
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 23.12
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 23.11
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 23.03
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 23.01
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 22.97
The Genomic Landscape of Atypical Fibroxanthoma 22.92
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 22.68
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 22.65
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 22.63
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 22.56
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 22.55
MCF10A H-Ras RNA-Seq 22.51
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 22.36
Survival of pancreatic cancer cells lacking KRAS function 22.31
Cerebellar differentiation in Ataxia-Telangiectasia 22.15
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 22.05
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 21.88
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 21.82
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 21.68
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 21.66
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 21.63
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 21.59
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 21.59
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 21.47
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 21.42
G-quadruplex structures mark human regulatory chromatin 21.4
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 21.22
CircRNAome diversity in human mature B-cells, T-cells and monocytes 21.2
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 21.15
Effect of Hotair overexpression in human breast cancer cell lines 21.06
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 20.8
A single-cell transcriptome atlas of the human pancreas 20.79
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 20.49
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 20.42
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 20.36
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 20.33
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 20.31
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 20.27
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 20.23
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 20.23
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 20.23
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 20.2
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 20.12
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 20.1
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 20.03
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 19.98
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 19.98
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 19.82
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 19.81
BI Human Reference Epigenome Mapping Project 19.75
RNA-Seq analysis of breast cancer cells after shikonin treatment 19.6
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 19.57
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 19.52
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 19.52
Ro60-knockout cells 19.39
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 19.39
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 19.39
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 19.3
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 19.27
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 19.19
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 19.15
A map of gene expression in neutrophil-like cell lines 19.11
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 19.1
Generation of KRAS signatures using immortalized isogenic lung cells. 19.04
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 19.01
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 19.01
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 18.95
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 18.76
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 18.72
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 18.72
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 18.72
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 18.66
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 18.66
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 18.58
PNET animal model: new insights (II) 18.53
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 18.51
Transcription elongation regulates genome 3D structure 18.5
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 18.48
HEXIM1 is induced by DHODH inhibition to suppress melanoma 18.48
Single-nucleotide-resolution mapping of HBV promoters using CAGE 18.43
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 18.28
RNAseq of IL-36 stimulated primary human keratinocytes 18.28
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 18.24
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 17.98
Evolution of a transcriptional regulator from a transmembrane nucleoporin 17.97
RNA-seq in HepG2 and IMR90 cells 17.97
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 17.96
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 17.88
Induced DNA demethylation, genome instability and transcription 17.88
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 17.87
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 17.86
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 17.82
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 17.81
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 17.81
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 17.8
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 17.8
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 17.74
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 17.74
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 17.64
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 17.64
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 17.64
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 17.56
Non-coding regions are the main source of tumor-specific antigens [human] 17.55
Non-coding regions are the main source of tumor-specific antigens 17.55
A prostate cancer chromatin interaction map 17.51
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 17.5
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 17.23
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 17.2
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 17.2
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 17.2
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 17.17
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 17.15
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 17.14
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 17.11
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 17.1
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 17.1
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 17.06
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 17.04
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 17.04
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 16.99
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 16.99
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 16.98
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 16.87
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 16.86
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 16.76
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 16.76
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 16.67
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 16.62
Transcriptome-wide identification of CELF2 functional targets in T cells 16.52
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 16.48
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 16.48
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 16.45
The interplay between SOX4 and SMAD3 in the context of breast cancer 16.37
Differentially expressed genes post knock down of lincDUSP26 16.32
RNA-sequencing in immortalized human mammary epithelial cells 16.31
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 16.31
SLAM-seq for K562 endogenous mRNA decay 16.29
Targeted enhancer activation by a subunit of the integrator complex 16.26
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 16.21
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 16.02
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 15.94
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 15.81
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 15.74
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 15.73
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 15.68
RNA-Seq from human ILC transitional populations 15.59
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 15.59
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 15.58
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 15.58
Aneuploidy triggers an immune response 15.5
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 15.38
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 15.34
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 15.34
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 15.17
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 15.16
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 15.06
Transcription control by the ENL YEATS domain in acute leukemia 15.04
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 15.04
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 14.92
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 14.84
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 14.77
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 14.77
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 14.69
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 14.54
Integrating single-cell transcriptomic data across different conditions, technologies, and species 14.43
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 14.39
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 14.34
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 14.32
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 14.28
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 14.18
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 14.18
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 13.95
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 13.95
The Glioma-Infiltrating T Cell Receptor Repertoire 13.93
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 13.9
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 13.9
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 13.87
Gene expression profile of human iPSC-derived nephron progenitor cells 13.85
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 13.76
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 13.75
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 13.65
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 13.62
MAIT cell RNA sequencing 13.48
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 13.45
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 13.42
RNA seq with AML (NB4) cells upon FTO inhibition 13.42
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 13.36
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 13.36
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 13.2
Transcriptomes of human monocytes after ex vivo exposure to uric acid 13.2
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 13.15
13.08
RNA-seq of MDA-MB-231 cells with TET1 knockout 12.9
The cytokine environment influence on human skin-derived T cells 12.89
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 12.68
Toxoplasma gondii infection of human retinal pigment epithelial cells 12.64
An siRNA screen identifies CHD4 as a target for epigenetic therapy 12.54
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 12.5
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 12.44
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 12.41
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 12.4
IRF1 regulates IFN dependent and independent gene expression 12.27
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 12.22
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 12.14
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 12.13
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 11.86
Selective expression of long non-coding RNAs in a breast cancer cell progression model 11.81
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 11.71
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 11.71
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 11.53
Genome-wide Analysis of Chromatin Interactions in Human Cells 11.41
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 11.22
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 11.17
Transcriptomic and gene ontology profiling of the human corneal cell types 11.1
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 10.98
Modeling Familial Cancer with iPSC Approaches 10.97
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 10.96
Transcriptome analysis reveals differential splicing events in IPF lung tissue 10.95
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 10.85
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 10.7
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 10.63
Human T-cell lymphoblastic lymphoma samples and control thymuses 10.6
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 10.6
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 10.46
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 10.42
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 9.96
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 9.96
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 9.8
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 9.69
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 9.69
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 9.66
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 9.49
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 9.33
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 9.04
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 8.99
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 8.99
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 8.75
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 8.73
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 8.64
Common inflammatory pathways between NEC and Crohn's disease 8.63
Identification of long noncoding RNAs in T-ALL cell lines 8.54
Investigate A2M treatment on human prostate cancer and mouse liver 8.31
Investigate A2M treatment on human prostate cancer xenograft in mice 8.31
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 8.16
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 8.16
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 8.11
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 8.09
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 7.99
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 7.99
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 7.93
Transcriptome analysis of kidney organoids 7.91
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 7.85
iPSC derived motor neuron cultures from C9ORF72 carriers 7.79
Trascriptome of thyroid cancer-induced macrophages 7.74
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 7.53
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 7.53
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 7.4
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 7.35
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 7.33
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 7.21
Functional Haploid Human Oocytes Generated from Polar Body Genomes 7.21
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 7.18
Gene profiling of human adult and pediatric liver cancer cells 7.17
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 7.02
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 6.99
Activity-dependent transcriptional changes in human neurons 6.93
Transcriptome of diurnal human blood neutrophils 6.88
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.77
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 6.61
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 6.61
Zika virus infection reprograms global transcription of host cells to allow sustained infection 6.59
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 6.46
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 6.31
Metastasis in triple-negative breast cancer 6.31
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 6.18
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 5.65
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 5.64
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 5.61
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.54
RNA Seq of Alagille liver biopsies 5.49
Alagille_Nodder 5.49
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 5.43
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 5.29
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 5.29
Dilated cardiomyopathy vs Myocarditis 5.24
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 5.23
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 5.03
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 4.99
Glucose inhibits cardiac maturation through nucleotide biosynthesis 4.9
Energy Metabolism during Anchorage-Independence 4.85
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 4.78
Unique features and clinical importance of acute alloreactive immune responses 4.71
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.68
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.68
RNA expression profiles comparing primary and omental ovarian carcinoma samples 4.68
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 4.68
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 4.58
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 4.37
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 4.37
The bromodomain protein BRD4 regulates splicing during heat shock 4.31
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 4.28
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 4.03
The gene expression profiles of gallbladder cancer 3.95
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 3.91
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.89
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 3.81
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.77
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 3.49
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.41
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 3.4
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 3.24
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 3.24
The transcriptome of Kawasaki Disease arteritis 3.05
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 2.86
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 2.63
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.58
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.58
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 2.34
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 2.34
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.3
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.3
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.26
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.26
Identification of differentially expressed genes between senescence and senescence bypass cells 2.23
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.08
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 2.05
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.99
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.89
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.85
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.77
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 1.69
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.69
Evaluating pre-clinical models for studying NASH driven HCC. 1.68
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.68
Effects of transcription on genome - nuclear lamina interactions 1.68
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.48
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 1.35
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.31
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.3
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.3
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 1.17
Human islets of varying quality: the good, the (not so) bad and the ugly 0.97
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.96
Impact on erythroid progenitor type on erythroid differntiation 0.78
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.74
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.72
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 0.7
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.68
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.64
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.61
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.61
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.47
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.34
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.27
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.22
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.2
Gene expression analysis of breast cancer cell-lines 0.19
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.19
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 0.19
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.13


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation